{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:13:14Z","timestamp":1789042394723,"version":"build-2803163510"},"reference-count":53,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) primarily participates in protein synthesis by binding aminoacyl-tRNA complexes to facilitate peptide chain elongation on ribosomes. Its expression and functional roles exhibit significant heterogeneity across various malignancies, exerting dual regulatory effects as both an oncogene and a tumor suppressor. This study aims to investigate the potential prognostic value and tumor-suppressive role of EEF1A1 in kidney renal clear cell carcinoma (KIRC). Methods: We analyzed the differential expression of EEF1A1 in KIRC and its correlation with patient prognosis based on the TCGA, GEO, and HPA databases. The STRING and GEPIA databases were utilized to perform functional enrichment analysis of its interacting proteins and co-expressed genes. The xCell algorithm was employed to assess the correlation between EEF1A1 and immune cell infiltration, immune checkpoints, and immunomodulatory molecules. Furthermore, drug sensitivity analysis was conducted to evaluate its clinical application potential. Finally, the expression of EEF1A1 in 786-0 and A498 cell lines was validated via qRT-PCR and Western blotting. Furthermore, CCK-8, wound healing, and Transwell migration\/invasion assays were performed to evaluate cell proliferation, migration, and invasion, respectively. Results: EEF1A1 may function as a negative regulator of malignant behaviors in KIRC tissues and cell lines, and its expression level was closely associated with clinicopathological features and prognosis of patients. GO, KEGG, and GSEA enrichment analyses revealed that low EEF1A1 expression is closely linked to immunosuppressive pathways. Further immunological analysis confirmed significant correlations between EEF1A1 and various immune cell infiltrates, immune checkpoints, tumor-infiltrating lymphocytes, and immunomodulatory molecules. Moreover, cells with high EEF1A1 expression exhibited increased sensitivity to anti-tumor drugs, with expression levels negatively correlated with inhibitory activity (IC50). Finally, overexpression of EEF1A1 significantly inhibited the proliferation, migration, and invasion of clear cell renal cell carcinoma cells. Conclusions: EEF1A1 serves as a potential prognostic biomarker in KIRC and is associated with clinical progression, immune-related characteristics, metabolic pathways, and drug sensitivity. Functional validation further supports its role in regulating malignant phenotypes of KIRC cells.<\/jats:p>","DOI":"10.3390\/cancers18182938","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:38:39Z","timestamp":1789040319000},"page":"2938","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Value of EEF1A1 and Its Correlation with Immune Regulation in Kidney Renal Clear Cell Carcinoma"],"prefix":"10.3390","volume":"18","author":[{"given":"Qiang","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sensen","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-2589","authenticated-orcid":false,"given":"Xiancheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal Cell Carcinoma: A Review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"ref_2","first-page":"2022-vol3","article-title":"Renal cell carcinoma: An overview of the epidemiology, diagnosis, and treatment","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G. Ital. Nefrol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1046\/j.1432-1033.2002.03290.x","article-title":"Regulation of peptide-chain elongation in mammalian cells","volume":"269","author":"Browne","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Abbas, W., Kumar, A., and Herbein, G. (2015). The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections. Front. Oncol., 5.","DOI":"10.3389\/fonc.2015.00075"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Blanch, A., Robinson, F., Watson, I.R., Cheng, L.S., and Irwin, M.S. (2013). Eukaryotic Translation Elongation Factor 1-Alpha 1 Inhibits p53 and p73 Dependent Apoptosis and Chemotherapy Sensitivity. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066436"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1242\/jcs.192831","article-title":"Inappropriate expression of the translation elongation factor 1A disrupts genome stability and metabolism","volume":"129","author":"Tarrant","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12935-024-03330-4","article-title":"CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41419-022-04930-6","article-title":"A novel 3\u2019tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer","volume":"13","author":"Cui","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3708640","DOI":"10.1155\/mi\/3708640","article-title":"Single-Cell Transcriptomics Uncover EEF1A1-Driven Ubiquitination Dysregulation in T Cell Exhaustion and SLE Pathogenesis via STAT1-Mediated Th1\/Th2 Imbalance","volume":"2025","author":"Xing","year":"2025","journal-title":"Mediat. Inflamm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13062-024-00495-w","article-title":"UCHL3 promotes hepatocellular carcinoma progression by stabilizing EEF1A1 through deubiquitination","volume":"19","author":"Zhao","year":"2024","journal-title":"Biol. Direct"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1158\/0008-5472.CAN-23-3638","article-title":"FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis","volume":"84","author":"Su","year":"2024","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2023","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wu, A., Tang, J., Guo, Z., Dai, Y., Nie, J., Hu, W., Liu, N., Ye, C., Li, S., and Pei, H. (2021). Long Non-Coding RNA CRYBG3 Promotes Lung Cancer Metastasis via Activating the eEF1A1\/MDM2\/MTBP Axis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22063211"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"109602","DOI":"10.1016\/j.bioorg.2026.109602","article-title":"Identification of EEF1A1 as a therapeutic target in TNBC: Anticancer action of a novel Penicillide-derived inhibitor through ribosomal protein regulation","volume":"172","author":"Yu","year":"2026","journal-title":"Bioorganic Chem."},{"key":"ref_15","first-page":"714","article-title":"Genome-wide target interactome profiling reveals a novel EEF1A1 epigenetic pathway for oncogenic lncRNA MALAT1 in breast cancer","volume":"9","author":"Li","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4161\/sgtp.2.2.15603","article-title":"Translational connection of TGF\u03b2 signaling: Phosphorylation of eEF1A1 by T\u03b2R-I inhibits protein synthesis","volume":"2","author":"Lin","year":"2011","journal-title":"Small GTPases"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/bs.apcsb.2023.10.001","article-title":"Understanding functions of eEF1 translation elongation factors beyond translation. A pro-teomic approach","volume":"138","author":"Negrutskii","year":"2024","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14462","DOI":"10.18632\/oncotarget.14895","article-title":"The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types","volume":"8","author":"Fancello","year":"2017","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/bmm.14.115","article-title":"Low level of the X-Linked Ribosomal Protein S4 in Human Urothelial Carcinomas is Associated With a Poor Prognosis","volume":"9","author":"Paquet","year":"2015","journal-title":"Biomark. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"BSR20211577","DOI":"10.1042\/BSR20211577","article-title":"Deregulation of ribosomal proteins in human cancers","volume":"41","author":"Nasr","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/onc.2012.63","article-title":"Ribosomal protein S14 unties the MDM2\u2013p53 loop upon ribosomal stress","volume":"32","author":"Zhou","year":"2012","journal-title":"Oncogene"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-020-01607-w","article-title":"ACYP2 contributes to malignant progression of glioma through promoting Ca2+ efflux and subsequently activating c-Myc and STAT3 signals","volume":"39","author":"Li","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105684","DOI":"10.1016\/j.jbc.2024.105684","article-title":"Elongation factor 1A1 regulates metabolic substrate preference in mammalian cells","volume":"300","author":"Wilson","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Leg\u00e1tov\u00e1, A., Pelantov\u00e1, M., R\u00f6sel, D., Br\u00e1bek, J., and \u0160karkov\u00e1, A. (2023). The emerging role of microtubules in invasion plasticity. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1118171"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41419-025-07690-1","article-title":"PCSK9 promotes progression of anaplastic thyroid cancer through E-cadherin endocytosis","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, H., Cai, J., Yu, S., Sun, B., and Zhang, W. (2023). Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065184"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.chembiol.2021.08.006","article-title":"A photoaffinity labeling strategy identified EF1A1 as a binding protein of cyclic dinucleotide 2\u20323\u2032-cGAMP","volume":"29","author":"Hou","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"107195","DOI":"10.1016\/j.phrs.2024.107195","article-title":"The eEF1A protein in cancer: Clinical significance, oncogenic mechanisms, and targeted therapeutic strategies","volume":"204","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Xu, B., Liu, L., and Song, G. (2022). Functions and Regulation of Translation Elongation Factors. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.816398"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s44318-024-00319-7","article-title":"Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation","volume":"44","author":"Estephan","year":"2025","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/s41388-025-03361-9","article-title":"Deciphering cancer complexity: Perspective on hematopoietic remodeling-mediated immunosuppression","volume":"44","author":"Liao","year":"2025","journal-title":"Oncogene"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41419-023-06119-x","article-title":"Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: New insights and therapeutic implications","volume":"14","author":"Fang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Yu, J., Fu, L., Wu, R., Che, L., Liu, G., Ran, Q., Xia, Z., Liang, X., and Zhao, G. (2025). Immunocytes in the tumor microenvironment: Recent updates and interconnections. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1517959"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/s41416-025-03133-y","article-title":"Moving beyond cytotoxicity in cancer immunotherapy: Embracing tumor microenvironment remodeling for durable control","volume":"133","author":"Koelsch","year":"2025","journal-title":"Br. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhu, H., Shao, J., Shao, L., Cai, L., Gu, C., Ge, Q., and Liu, J. (2025). Immunotherapy strategies targeting tumor-associated macrophages and their mechanisms of action in tumor progression. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1680455"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e70345","DOI":"10.1002\/ctm2.70345","article-title":"Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy","volume":"15","author":"Xiang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00262-024-03773-8","article-title":"TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3","volume":"73","author":"Perales","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1074\/jbc.RA119.007455","article-title":"Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation","volume":"294","author":"Maeda","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116606","DOI":"10.1016\/j.celrep.2025.116606","article-title":"Protein kinase C\u03b9 dictates tumor trajectory, cell plasticity, and immune surveillance in lung adenocarcinoma","volume":"44","author":"Nguyen","year":"2025","journal-title":"Cell Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13048-024-01496-z","article-title":"Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer","volume":"17","author":"Wang","year":"2024","journal-title":"J. Ovarian Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12943-023-01761-7","article-title":"Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF\/FGFR signaling in tumor microenvironment","volume":"22","author":"Ruan","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2258011","DOI":"10.1080\/2162402X.2023.2258011","article-title":"CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response","volume":"12","author":"Charpentier","year":"2023","journal-title":"OncoImmunology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000496166","article-title":"B Cell-Based Cancer Immunotherapy","volume":"46","author":"Wennhold","year":"2019","journal-title":"Transfus. Med. Hemotherapy"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tranon.2017.11.001","article-title":"eEF1A1 Overexpression Enhances Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma","volume":"11","author":"Chen","year":"2018","journal-title":"Transl. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sabur, A., Bhowmick, S., Chhajer, R., Ejazi, S.A., Didwania, N., Asad, M., Bhattacharyya, A., Sinha, U., and Ali, N. (2018). Liposomal Elongation Factor-1\u03b1 Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00018"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fuentes, J.D.B., Arcilla, J.B., Mohamed, K.M., de Sa, A.L., Aguilar, A.d.L., Guevara-Hoyer, K., Martinez, P.B., Sanchez, A.D.L., Carosella, E.D., and Oca\u00f1a, A. (2024). Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer. Cancers, 16.","DOI":"10.3390\/cancers16244266"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.7150\/jca.110306","article-title":"HLA-DOB: A Key \u201cCoordinator\u201d Between Cutaneous Melanoma and Psoriasis","volume":"16","author":"Li","year":"2025","journal-title":"J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1158\/1541-7786.MCR-22-0872","article-title":"Tumor-derived CCL5 recruits cancer-associated fibroblasts and promotes tumor cell proliferation in esophageal squamous cell carcinoma","volume":"21","author":"Dunbar","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Xu, D., Liu, X., Ke, S., Guo, Y., Zhu, C., and Cao, H. (2023). CCL19\/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer. BMC Cancer, 23.","DOI":"10.1186\/s12885-023-10882-7"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"101842","DOI":"10.1016\/j.tranon.2023.101842","article-title":"Transcriptionally activates CCL28 expression to inhibit M2 polarization of macrophages and prevent immune escape in colorectal cancer cells","volume":"40","author":"Li","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109448","DOI":"10.1016\/j.isci.2024.109448","article-title":"Systematic omics analysis identifies CCR6 as a therapeutic target to overcome cancer resistance to EGFR inhibitors","volume":"27","author":"Kwon","year":"2024","journal-title":"iScience"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10585-021-10103-0","article-title":"CXCL2-CXCR2 axis mediates \u03b1V integrin-dependent peritoneal metastasis of colon cancer cells","volume":"38","author":"Lepsenyi","year":"2021","journal-title":"Clin. Exp. Metastasis"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2938\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:45:46Z","timestamp":1789040746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":53,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18182938"],"URL":"https:\/\/doi.org\/10.3390\/cancers18182938","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}